Form 4: Health Catalyst CEO Sells Shares to Cover Tax Obligations Following RSU Vesting
Insider Transaction Report
Health Catalyst, Inc.'s CEO, Daniel D. Burton, disposed of 8,658 shares of common stock on June 2, 2025, in a non-discretionary 'sell to cover' transaction related to tax withholding from Restricted Stock Unit vesting.
Summary
- Daniel D. Burton, Chief Executive Officer and Director of Health Catalyst, Inc. (HCAT), disposed of 8,658 shares of common stock.
- The transaction occurred on June 2, 2025, at a price of $3.6348 per share.
- This sale was a non-discretionary 'sell to cover' transaction, mandated by the company's equity incentive plans to satisfy tax withholding obligations arising from the vesting of Restricted Stock Units.
- Following this transaction, Mr. Burton beneficially owns 1,457,149 shares of Health Catalyst common stock directly.
Sentiment
Score: 5
Explanation: The transaction is a routine 'sell to cover' for tax purposes related to RSU vesting, which is a non-discretionary event and does not reflect a change in management's discretionary view of the company's prospects. Therefore, it is neutral in sentiment.
Positives
- The transaction is a standard 'sell to cover' for tax obligations, indicating the vesting of Restricted Stock Units (RSUs) for the CEO.
- The CEO continues to hold a substantial beneficial ownership of 1,457,149 shares of common stock after the transaction.
Negatives
- The disposition of shares was not a discretionary sale by the CEO, but rather a mandatory transaction to cover tax withholding obligations.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The transaction is a routine 'sell to cover' and does not indicate a change in the CEO's long-term commitment or outlook for the company, thus having minimal direct impact.
- Employees: The vesting of RSUs and subsequent tax-related sale is a standard part of executive compensation, reflecting the company's equity incentive plans.
Key Dates
| Date | Description |
|---|---|
| 06/02/2025 | Date of transaction where shares were disposed of to cover tax withholding obligations. |
| 06/03/2025 | Date the Form 4 was filed with the SEC. |
Keywords
Health Catalyst, HCAT, SEC Form 4, Insider Transaction, Stock Sale, Restricted Stock Units, RSU Vesting, Tax Withholding, CEO, Daniel D. Burton, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.